Company Krebs Biochemicals & Industries Limited NSE India S.E.
Equities
KREBSBIO
INE268B01013
Pharmaceuticals
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
85.07 INR | +1.75% |
|
+0.82% | +8.58% |
Business Summary
Number of employees: 210
Sales per Business
INR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Active Pharmaceutical Ingredients
100.0
%
| 529 | 100.0 % | 521 | 100.0 % | -1.52% |
Sales per region
INR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
India
100.0
%
| 529 | 100.0 % | 521 | 100.0 % | -1.52% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jitendra Shah
CEO | Chief Executive Officer | - | 21-11-08 |
Founder | 74 | 91-12-01 | |
Ritesh Jain
DFI | Director of Finance/CFO | - | 23-02-02 |
Director/Board Member | 55 | - | |
Avinash Ravi
BRD | Director/Board Member | 45 | 01-12-31 |
Sudhir Manne
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 68 | 00-09-25 | |
Founder | 74 | 91-12-01 | |
Avinash Ravi
BRD | Director/Board Member | 45 | 01-12-31 |
Director/Board Member | 75 | 16-02-11 | |
Malati Tangirala
BRD | Director/Board Member | 74 | 13-12-31 |
Director/Board Member | 79 | 15-09-28 | |
Director/Board Member | 55 | - | |
Jitendra Shah
CEO | Chief Executive Officer | - | 21-11-08 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 21,560,600 | 4,839,509 ( 22.45 %) | 0 | 22.45 % |
Company contact information
Krebs Biochemicals & Industries Ltd.
Plot No.34, 8-2-577/B 3rd Floor, Maas Heights
500034, Hyderabad
+
http://krebsbiochem.com![address Krebs Biochemicals & Industries Limited(KREBSBIO)](https://cdn.zonebourse.com/static/address/34067630.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+25.40% | 45.35B | |
+38.38% | 24.34B | |
+26.46% | 16.51B | |
+21.19% | 14.6B | |
+71.91% | 14.27B | |
-0.05% | 6.79B | |
-11.63% | 6.57B | |
+15.08% | 5.76B | |
-8.87% | 5.73B |
- Stock Market
- Equities
- KREBSBIO Stock
- KREBSBIO Stock
- Company Krebs Biochemicals & Industries Limited